An Investigator-Initiated Trial of a Polymeric Emulsion of Halobetasol Propionate and Tazarotene in the Treatment of Palmoplantar Psoriasis
Journal of Drugs in Dermatology · 2023
DOI: 10.36849/jdd.7067 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Drugs in Dermatology, 2023. Verfasst von Jenna Yousif und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatologic Agents, Nicotinic Acids, Psoriasis.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Yousif, J., Babalola, F., Campbell, C., Gottlieb, A., Vargas, J., & Mitchell, K. (2023). An Investigator-Initiated Trial of a Polymeric Emulsion of Halobetasol Propionate and Tazarotene in the Treatment of Palmoplantar Psoriasis. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7067
Vancouver
Yousif J, Babalola F, Campbell C, Gottlieb A, Vargas J, Mitchell K. An Investigator-Initiated Trial of a Polymeric Emulsion of Halobetasol Propionate and Tazarotene in the Treatment of Palmoplantar Psoriasis. Journal of Drugs in Dermatology. 2023. doi:10.36849/jdd.7067
BibTeX
@article{Yousif2023,
author = {Yousif, Jenna and Babalola, Folawiyo and Campbell, Caroline and Gottlieb, Alice and Vargas, Jessica and Mitchell, Krystal},
title = {An Investigator-Initiated Trial of a Polymeric Emulsion of Halobetasol Propionate and Tazarotene in the Treatment of Palmoplantar Psoriasis},
journal = {Journal of Drugs in Dermatology},
year = {2023},
doi = {10.36849/jdd.7067}
}
EUVIMED